Risk Of Anaphylactic Reaction Associated With Glatiramer Acetate, Used To Treat Multiple Sclerosis
Glatiramer Acetate Recall Summary Glatiramer acetate, a medication used to treat multiple sclerosis, is being recalled across Canada due to a newly identified risk of anaphylactic reaction (a severe allergic response). This recall affects all glatiramer acetate products distributed in Canada. Healthcare providers and patients currently using this medication are being notified of this safety concern.
- Product
- Glatiramer acetate
- Reason
- Product safety - New safety information
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2025-08-21
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/c6557f73-0ff9-4a6e-9847-d27320677225